Jacobio Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Jacobio Pharmaceuticals Co., Ltd., explained in plain language.
-
New cancer drug JAB-8263 tested in humans for first time
Disease control CompletedThis early-stage study tested a new drug called JAB-8263 in 41 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find the safest dose and to check for side effects. The study was completed, but it was too small and early …
Phase: PHASE1 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New drug targets tough cancer mutation in early trial
Disease control CompletedThis study tested a drug called JAB-21822 in 29 adults with advanced solid tumors (like lung or colon cancer) that have a specific genetic change called KRAS G12C. The goal was to see if the drug is safe and can shrink tumors. Participants took the drug alone or with another medi…
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug combo shows promise in advanced cancer trial
Disease control CompletedThis early-phase study tested a new drug called JAB-BX102, given alone or with another drug (pembrolizumab), in 21 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose, while also looking…
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC